Functional genetic variation in BDNF (brain-derived neurotrophic factor) is posited to impact neural activity in the hippocampus in a manner relevant to schizophrenic pathophysiology. To test this hypothesis, 47 medication-free patients with schizophrenia or schizoaffective disorder and 74 healthy control individuals underwent genotyping for the BDNF Val66Met single-nucleotide polymorphism and [15O]H2O positron emission tomography during rest, sensorimotor (0 bk) and working memory (2 bk) conditions. When compared with their genotype-matched control cohort, only patients carrying the BDNF Met variant showed diminished mean whole-hippocampus perfusion, regardless of scanning condition (bar graphs; Bonferroni-corrected post-hoc tests: P ¼ 0.0004 (rest), P ¼ 0.004 (0 bk), P ¼ 0.02 (2 bk)). Mean voxel-wise resting perfusion maps rendered to hippocampal surfaces are likewise shown for each group with warmer colors (color bar), indicating greater normalized regional cerebral blood flow values.

